HTLV-I infection: a dynamic struggle between viral persistence and host immunity
Human T-lymphotropic virus type I (HTLV-I) causes chronic infection for which there is no
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …
[PDF][PDF] HTLV-I infection: A dynamic struggle between viral persistence and host immunity
AG Lim, PK Maini - Journal of Theoretical Biology, 2014 - people.maths.ox.ac.uk
abstract Human T-lymphotropic virus type I (HTLV-I) causes chronic infection for which there
is no cure or neutralising vaccine. HTLV-I has been clinically linked to the development of …
is no cure or neutralising vaccine. HTLV-I has been clinically linked to the development of …
HTLV-I infection: a dynamic struggle between viral persistence and host immunity
AG Lim, PK Maini - Journal of theoretical biology, 2014 - pubmed.ncbi.nlm.nih.gov
Human T-lymphotropic virus type I (HTLV-I) causes chronic infection for which there is no
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …
HTLV-I infection: A dynamic struggle between viral persistence and host immunity
AG Lim, PK Maini - Journal of Theoretical Biology, 2014 - ui.adsabs.harvard.edu
Human T-lymphotropic virus type I (HTLV-I) causes chronic infection for which there is no
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …
HTLV-I infection: a dynamic struggle between viral persistence and host immunity.
AG Lim, PK Maini - Journal of Theoretical Biology, 2014 - europepmc.org
HTLV-I infection: a dynamic struggle between viral persistence and host immunity. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
[PDF][PDF] HTLV-I infection: A dynamic struggle between viral persistence and host immunity
AG Lim, PK Maini - Journal of Theoretical Biology, 2014 - core.ac.uk
abstract Human T-lymphotropic virus type I (HTLV-I) causes chronic infection for which there
is no cure or neutralising vaccine. HTLV-I has been clinically linked to the development of …
is no cure or neutralising vaccine. HTLV-I has been clinically linked to the development of …
HTLV-I infection: A dynamic struggle between viral persistence and host immunity
AG Lim, PK Maini - Journal of Theoretical Biology, 2014 - infona.pl
Human T-lymphotropic virus type I (HTLV-I) causes chronic infection for which there is no
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …
HTLV-I infection: A dynamic struggle between viral persistence and host immunity
AG Lim, PK Maini - Journal of Theoretical Biology, 2014 - research-information.bris.ac.uk
Human T-lymphotropic virus type I (HTLV-I) causes chronic infection for which there is no
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …
[引用][C] HTLV-I infection: A dynamic struggle between viral persistence and host immunity
AG Lim, PK Maini - Journal of Theoretical Biology, 2014 - cir.nii.ac.jp
HTLV-I infection: a dynamic struggle between viral persistence and host immunity.
AG Lim, PK Maini - 2014 - cabidigitallibrary.org
Human T-lymphotropic virus type I (HTLV-I) causes chronic infection for which there is no
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T …